15 các kết quả
PRIORITY
The present application claims the benefit of Indian Provisional Patent Application No. 1857/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/051482 filed on 24 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into
PRIORITY
The present application claims the benefit of Indian Provisional Patent Application No. 1838/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/050917 filed on 4 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into this
PRIORITY
The present application claims the benefit of Indian Provisional Patent Application No. 1840/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/050924 filed on 4 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into this
PRIORITY
The present application claims the benefit of Indian Provisional Patent Application No. 1834/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/050909 filed on 3 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into this
BACKGROUND OF THE INVENTION
The present invention relates to novel heterocyclic carboxamides to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention include selective agonists and antagonists of
TECHNICAL FIELD
The present invention relates to using a portable thermal device to reduce accommodation of thermal nerve receptors, for example, a user-controllable variable-heat cycle thermal device.
BACKGROUND
In 1965, Melzack and Wall described the physiologic mechanisms by which stimulation of
TECHNICAL FIELD
The present invention relates to using a portable thermal device to reduce accommodation of thermal nerve receptors, for example, a user-controllable variable-heat cycle thermal device.
BACKGROUND
In 1965, Melzack and Wall described the physiologic mechanisms by which stimulation of
FIELD OF THE DISCLOSURE
The present disclosure relates to nutritional supplements. Specifically, the present disclosure relates to nutritional supplements used to treat and/or prevent inflammation and disease states and conditions resulting from inflammation.
BACKGROUND
The human diet has been known
PRIORITY
The present application claims the benefit of Indian Provisional Patent Application No. 1808/CHE/2012 filed on 8 May 2012 and the International Application No. PCT/IB2013/050887 filed on 2 Feb. 2013; the entire disclosure of which is relied on for all purposes and is incorporated into this
FIELD OF THE INVENTION
This disclosure generally relates to compounds and compositions for the treatment of moderate to severe pain. More particularly, this invention relates to treating subjects with a pharmaceutically acceptable dose of compounds, crystals, enantiomers, stereoisomers, esters,
PRIORITY
This application is a national phase filing of the Patent Cooperation Treaty (PCT) application # PCT/IB2013/055146 titled "COMPOSITIONS AND METHODS FOR THE TREATMENT OF MODERATE TO SEVERE PAIN" filed on Jun. 23, 2013 Published with WIPO Publication # WO/2014/006529, which further claims
BACKGROUND
The field of the present invention relates to the delivery of energy impulses (and/or energy fields) to bodily tissues for therapeutic purposes. The invention relates more specifically to the use of non-invasive or minimally-invasive electrical stimulation of the vagus nerve in a
BACKGROUND OF THE INVENTION
The field of the present invention relates to the delivery of energy impulses (and/or energy fields) to bodily tissues for therapeutic purposes. The invention relates more specifically to the use of non-invasive or minimally-invasive electrical stimulation of the vagus
TECHNICAL FIELD
Embodiments disclosed herein generally relate to a method of treatment for weight-loss and other conditions in a mammal. More particularly, embodiments herein are directed to anatomically targeted, low-dosage delivery of antiepileptic/anticonvulsant compounds for weight-loss and
BACKGROUND OF THE INVENTION
An analgesic is a drug that relieves pain (analgesia). These "pain killers" are not anesthetics. Anesthetics reversibly eliminate sensation, while analgesics raise the level of sensitivity to pain. Analgesic medications may be administered intravenously, orally, or